LSPedia Newsletter

In this edition: A regulator’s take on DSCSA, LSPedia achieves FedRAMP In-Process designation, pharmacists earn CE credits through hands-on DSCSA training, and more!

In this edition: AI & ML are Revolutionizing Regulatory Affairs, Optimizing Supply Chains with ASNs, LSPedia CEO, Riya Cao Launches Executive Newsletter and more!

DSCSA Enforcement Begins May 27 – 6 Critical Actions to Protect Your Shipments ‍FDA enforcement is around the corner. LSPedia outlines six key actions—like validating EPCIS connections and resolving exceptions—to help manufacturers and repackagers stay compliant and keep shipments moving.

LSPedia销售总监马特·文森特详细介绍了美国食品药品管理局的DSCSA豁免及其在稳定期于2024年11月27日结束时的重要性。

欢迎阅读我们的合规更新，点击链接阅读更多

LSPedia’s SVP of Sales and Marketing, Daniel MacKinnon, recently traveled across India to meet with top pharmaceutical manufacturers facing growing frustrations with outdated systems and poor support. In his latest blog, he shares how these challenges drive companies to switch to LSPedia for reliable, high-performing solutions

Discover how Baptist Health transformed compliance and operational workflows with LSPedia’s OneScan Suite.

LspEdia 很高兴推出新的 WEE 管理模块，作为即将于 2024 年 10 月 6 日发布的 OneScan 7.3 版本的一部分。

LspEdia推出了新的豁免、例外和豁免（WEE）资源页面，为那些考虑申请额外时间豁免以实现DSCSA合规以及如何与贸易伙伴一起管理WEE的紧迫问题提供了基本答案。

在制药行业，维持弹性和可持续的供应链对于确保产品完整性、合规性和运营效率至关重要。

LspEdia推出了OneScan 7.1，这是一款领先的可追溯性解决方案，受到全球主要医疗保健品牌的信赖。

在新的一年里，DSCSA 合规性步入正轨。在本期中，我们将讨论有关LSPedia入选退伍军人事务部的激动人心的新闻等等

DSCSA 的截止日期快到了。在本版本中，我们将讨论与Redsail的合作伙伴关系等等